11/04/2026
The problem with the label "Profound Autism" well explained by PANDA
Musings of an autist … “profound autism” … they retired “low-functioning.” Then they brought it back …
There is a term gaining ground in autism research, policy, and media right now that I think deserves serious scrutiny.
That term is “profound autism.”
I want to explain where it came from, what it actually means, why it is being contested so fiercely, and what is really at stake - not just in academic journals, but for real children, real adults, and real families.
Let me start with a fact that surprises most people: “profound autism” was not invented as a diagnosis.
The 2021 Lancet Commission on the Future of Care and Clinical Research in Autism proposed it as an administrative term - a planning tool to help identify a group of autistic people who would need intensive, lifelong support.
The Commission’s own co-chair, Professor Catherine Lord, described its purpose as creating “useful categories that might bring attention to the different needs of different people.”
The Commission explicitly said this designation was “not appropriate for young children,” and acknowledged that some children who met the criteria at age nine had moved out of the category by eighteen.
It was, in the Commission’s own framing, fluid and functional - not a fixed diagnostic subtype.
What has happened since is something else entirely.
Organisations including the Autism Science Foundation and the National Council on Severe Autism have pushed hard to turn this administrative shorthand into a formal DSM diagnostic category - a distinct, codified type of autism.
That is a very different proposition.
And it is one that a growing body of autistic academics, clinicians, and disability rights organisations believes is built on shaky ground.
So what does “profound autism” actually mean?
The Lancet Commission defined it as being nonspeaking or minimally speaking, and/or having an IQ below 50, combined with needing around-the-clock support.
Here is the first major problem: “and/or.” In the CDC’s own 2023 data - the largest study to apply this definition in practice - most children who qualified for the label did so on the basis of only one of the two criteria.
Around 38 per cent qualified solely because they were minimally speaking.
Another 43 per cent qualified solely because of a low IQ score.
Only around 19 per cent met both.
This matters enormously: the population of non-speaking autistic people has very little overlap with the population of autistic people with IQ scores below 50.
They are not the same group.
A definition designed to reduce heterogeneity in autism research has, paradoxically, created a label that lumps together two quite different groups of people.
Heterogeneity was the problem. This definition has not solved it.
The IQ criterion deserves particular attention, because it rests on an evidential foundation that is far more fragile than most people realise.
Standard IQ tests were not designed for non-speaking autistic people. They rely heavily on verbal responses and timed tasks.
Research has consistently shown that non-speaking autistic people are routinely misclassified as having intellectual disabilities - not because of their actual cognitive ability, but because the tests cannot access it.
Many non-speaking autistic people who gain access to augmentative and alternative communication (AAC) devices, picture boards, letter boards, typing, demonstrate far higher levels of understanding and intelligence than any IQ test had suggested.
The American Speech-Language-Hearing Association states plainly that “spoken language is not the sole indicator of intelligence or understanding.”
Using a sub-50 IQ score as a diagnostic criterion for a new subgroup of autism, when we know those scores are frequently wrong for the very population in question, is not evidence-based practice. It is building on sand.
There is another layer to this that does not get nearly enough attention: apraxia.
Childhood apraxia of speech is a motor disorder - a problem with coordinating the movements needed to produce speech.
It is not a problem of comprehension, intelligence, or intention.
Research suggests it may affect close to two-thirds of autistic children, and it is a primary reason why many children do not speak.
An apraxic child who cannot reliably produce speech is not a child without language or understanding. They are a child with a motor speech difficulty who needs specific, appropriate support to find another way to communicate.
When that child gets labelled “profoundly autistic” on the basis of being non-speaking, the real reason they are not speaking - apraxia - risks being missed entirely.
And this brings us to what autistic academics Richard Woods, Kathryn Williams, and C.A. Watts identified as one of the most serious clinical dangers of the “profound autism” label: diagnostic overshadowing.
Diagnostic overshadowing happens when clinicians attribute a person’s difficulties to an already-existing diagnosis, rather than looking for other explanations.
Woods, Williams, and Watts published a peer-reviewed letter in the journal Autism Research setting out their concerns that “profound autism” creates exactly this risk.
When a child or adult is labelled as “profoundly autistic,” clinicians and support workers may stop looking for other conditions - epilepsy, cerebral folate deficiency, anxiety disorders, motor conditions, even serious physical illness.
The authors document a case in which an autistic person’s symptoms of ALS - amyotrophic lateral sclerosis - were dismissed as “challenging behaviour” until just two months before they died. That person’s progressive muscle weakness was attributed to their autism. No one looked further.
Woods, Williams, and Watts are direct about this: if everything becomes “part of the autism,” conditions that are eminently treatable, or even life-saving to identify, go undetected.
It is also worth being honest about what “profound autism” fundamentally is: functioning labels under a new name.
For years, and through significant effort by autistic people themselves, and by the clinicians who listened to them, the field has moved away from “high-functioning” and “low-functioning” as descriptors.
These labels were abandoned because they are scientifically imprecise, practically useless, and profoundly harmful.
A person labelled “low-functioning” tends to get lower expectations, less educational ambition directed at them, and fewer opportunities.
A person labelled “high-functioning” tends to have their very real support needs dismissed.
The Autism Self-Advocacy Network has been clear that it will continue to oppose functioning labels in all forms. “Profound autism” is, in effect, the same binary repackaged. The label does not describe a biological reality. It describes a snapshot of observed behaviour often in systems that have not yet found the right tools to reach the person.
The CDC’s 2023 data surfaces something else that should give us pause.
Children classified as having “profound autism” are disproportionately female, from racial and ethnic minority groups, from low-income families, and born preterm.
This pattern is unlikely to reflect a straightforward neurological difference. It almost certainly reflects, at least in part, the fact that milder presentations of autism are systematically underdiagnosed in these groups meaning many of these children may have been classified as “profound” not because their needs are categorically different, but because adequate diagnosis, appropriate support, and access to AAC came too late or not at all. In other words, the label may be capturing systemic failure as much as it is capturing clinical reality.
ASAN Executive Director Julia Bascom has raised a concern that goes beyond clinical accuracy: the legal dimension.
Once a formal label like “profound autism” is applied and codified, it becomes easier for courts to grant conservatorships - legal arrangements that remove an adult’s autonomy and decision-making rights and hand them to a guardian.
Conservatorships are notoriously difficult to escape, even with evidence of mistreatment. A diagnostic label can be, and in some cases has been, used as a tool of control by abusive caregivers.
If the classification is later shown to have been wrong - if the person’s capacities were always far greater than the label implied - that may be very cold comfort by then.
And we cannot ignore the political context in which this debate is happening, particularly in the United States. Robert F. Kennedy Jr. has reshaped the Interagency Autism Coordinating Committee, the body that oversees around two billion dollars in federal autism research funding, packing it with individuals who have promoted the discredited claim that vaccines cause autism.
The WHO’s global vaccine safety committee has reviewed 31 primary studies and found no causal link between vaccines and autism spectrum disorders. Yet the IACC is now being steered by people committed to relitigating this.
“Profound autism” fits into this political moment: it fragments the autism community, pits parents of children with high support needs against autistic self-advocates, and provides a rhetorical hook for narrowing what counts as “real” or “serious” autism in ways that serve specific agendas.
Every pound and every dollar spent relitigating vaccine mythology is money not being spent on understanding communication, motor function, sensory needs, and what actually helps people.
None of this means the needs of autistic people who require intensive, lifelong support are not real, urgent, or deserving of priority.
They absolutely are.
But here is the thing: we do not need a new diagnostic label to meet those needs. The DSM-5 already includes specifiers for intellectual disability, language impairment, and levels of support required - levels one, two, and three.
The problem is not that these tools do not exist. The problem is that they are inconsistently used, underfunded, and not attached to the real-world service commitments that would make them meaningful.
What we need is not a new label. We need genuinely resourced AAC provision for every non-speaking autistic person who could benefit from it.
We need consistent, high-quality diagnostic practice that does not mistake systemic failure for individual deficit.
We need autistic people with high support needs to be included in research not because they have been given a special category, but because they are autistic people, full stop.
And we need the principle of presumed competence to be the default, not the exception: never assume that because a person cannot speak, they do not understand.
“Nothing about us without us” - that principle applies to autistic people who use speech and to those who do not.
The task is to find ways to include and hear everyone, not to create a category that effectively writes some people off as beyond the reach of that principle before they have been given the tools to prove otherwise.
I do not think those pushing for “profound autism” as a diagnostic category are, in the main, bad people. Many of them are exhausted parents who feel invisible, whose children’s very real needs have been dismissed and underfunded for years.
That frustration is legitimate and understandable.
But the answer to being poorly served is not a label that locks in low expectations. It is fighting for the resources, the research, the AAC access, and the clinical respect that every autistic person, regardless of how they communicate, has always deserved and will always deserve.
The word “profound,” I would suggest, should describe the depth of our commitment to getting this right - not the ceiling we place on what any person is assumed capable of.
